Supplemental Guarantor Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	$ 322.5	$ 325.7
Operating costs and expenses	265.6	306.5
Operating (loss) income	56.9	19.2
Interest expense (income), net	40.3	47.9
Other (income) expense, net	0.6	(0.3)
(Loss) income before equity in earnings of subsidiaries and income taxes	16.5	(30.3)
Income tax (benefit) expense	9.5	6.4
Net income (loss)	7.0	(36.7)
Total comprehensive income (loss)	8.8	(34.1)
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	4.4	(39.3)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	4.2	5.1
Other current assets	2.6		1.6
Total current assets	273.4		251.1
Property, plant and equipment, net	892.2		902.8
Investment in CyrusOne	462.2		471.0
Other noncurrent assets	34.8		36.6
Total assets	2,101.5		2,107.3
Current portion of long-term debt	12.1		12.6
Accounts payable	111.3		89.4
Other current liabilities	31.8		36.8
Total current liabilities	265.7		254.3
Long-term debt, less current portion	2,244.1		2,252.6
Other noncurrent liabilities	68.8		74.4
Total liabilities	2,772.2		2,784.0
Shareowners' (deficit) equity	(670.7)		(676.7)
Total liabilities and shareowners' equity (deficit)	2,101.5		2,107.3
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	37.8	42.3
Capital expenditures	(34.3)	(50.9)
Proceeds from sale of assets	1.9	0.8
Dividends received from CyrusOne	7.1	0
Cash divested from deconsolidation of CyrusOne	0	12.2
Cash flows used in investing activities	(25.3)	(61.9)
(Decrease) increase in receivables facility, net	(4.1)	2.0
Repayment of debt	(5.2)	(3.1)
Proceeds from exercise of options and warrants	0.6	6.6
Other financing activities	(1.7)	(2.3)
Cash flows provided by (used in) financing activities	(12.9)	1.1
(Decrease) increase in cash and cash equivalents	(0.4)	(18.5)
Cash and cash equivalents at beginning of period	4.6	23.6
Cash and cash equivalents at end of period	4.2	5.1
Notes guaranteed by parent [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	322.5	325.7
Operating costs and expenses	265.6	306.5
Operating (loss) income	56.9	19.2
Interest expense (income), net	40.3	47.9
Other (income) expense, net	0.1	1.6
(Loss) income before equity in earnings of subsidiaries and income taxes	16.5	(30.3)
Income tax (benefit) expense	9.5	6.4
Equity in earnings of subsidiaries, net of tax	0	0
Net income (loss)	7.0	(36.7)
Other comprehensive income (loss)	1.8	2.6
Total comprehensive income (loss)	8.8	(34.1)
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	4.4	(39.3)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	4.2	5.1
Receivables, net	177.0		154.8
Other current assets	92.2		91.7
Total current assets	273.4		251.1
Property, plant and equipment, net	892.2		902.8
Investment in CyrusOne	462.2		471.0
Goodwill and intangibles, net	105.6		106.1
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	368.1		376.3
Total assets	2,101.5		2,107.3
Current portion of long-term debt	12.1		12.6
Accounts payable	112.0		89.9
Other current liabilities	141.6		151.8
Total current liabilities	265.7		254.3
Long-term debt, less current portion	2,244.1		2,252.6
Other noncurrent liabilities	262.4		277.1
Intercompany payables	0		0
Total liabilities	2,772.2		2,784.0
Shareowners' (deficit) equity	(670.7)		(676.7)
Total liabilities and shareowners' equity (deficit)	2,101.5		2,107.3
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	37.8	42.3
Capital expenditures	(34.3)	(50.9)
Proceeds from sale of assets	1.9	0.8
Dividends received from CyrusOne	7.1
Cash divested from deconsolidation of CyrusOne		(12.2)
Other investing activities		0.4
Cash flows used in investing activities	(25.3)	(61.9)
Funding between Parent and subsidiaries, net	0	0
(Decrease) increase in receivables facility, net	(4.1)	2.0
Repayment of debt	(5.2)	(3.1)
Proceeds from exercise of options and warrants	0.6	6.6
Other financing activities	(4.2)	(4.4)
Cash flows provided by (used in) financing activities	(12.9)	1.1
(Decrease) increase in cash and cash equivalents	(0.4)	(18.5)
Cash and cash equivalents at beginning of period	4.6	23.6
Cash and cash equivalents at end of period	4.2	5.1
Notes guaranteed by parent [Member] | Parent Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	0	0
Operating costs and expenses	6.1	36.1
Operating (loss) income	(6.1)	(36.1)
Interest expense (income), net	37.1	35.8
Other (income) expense, net	(0.3)	(0.4)
(Loss) income before equity in earnings of subsidiaries and income taxes	(42.9)	(71.5)
Income tax (benefit) expense	(11.5)	(20.1)
Equity in earnings of subsidiaries, net of tax	38.4	14.7
Net income (loss)	7.0	(36.7)
Other comprehensive income (loss)	1.8	2.8
Total comprehensive income (loss)	8.8	(33.9)
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	4.4	(39.3)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.9	2.9
Receivables, net	1.9		2.6
Other current assets	20.4		4.4
Total current assets	24.2		9.1
Property, plant and equipment, net	0.1		0.1
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	1,437.6		1,406.6
Other noncurrent assets	332.8		359.1
Total assets	1,794.7		1,774.9
Current portion of long-term debt	5.4		5.4
Accounts payable	0.5		1.5
Other current liabilities	66.0		67.7
Total current liabilities	71.9		74.6
Long-term debt, less current portion	1,912.7		1,916.1
Other noncurrent liabilities	204.8		214.5
Intercompany payables	276.0		246.4
Total liabilities	2,465.4		2,451.6
Shareowners' (deficit) equity	(670.7)		(676.7)
Total liabilities and shareowners' equity (deficit)	1,794.7		1,774.9
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	(29.9)	(27.5)
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	37.1	24.4
(Decrease) increase in receivables facility, net	(2.5)	0
Repayment of debt	(1.3)	0
Proceeds from exercise of options and warrants	0.6	6.6
Other financing activities	(4.2)	(4.4)
Cash flows provided by (used in) financing activities	29.7	26.6
(Decrease) increase in cash and cash equivalents	(0.2)	(0.9)
Cash and cash equivalents at beginning of period	2.1	3.8
Cash and cash equivalents at end of period	1.9	2.9
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	173.6	180.5
Operating costs and expenses	161.0	173.4
Operating (loss) income	12.6	7.1
Interest expense (income), net	4.0	7.6
Other (income) expense, net	(1.5)	0.3
(Loss) income before equity in earnings of subsidiaries and income taxes	10.1	(0.8)
Income tax (benefit) expense	2.9	10.0
Equity in earnings of subsidiaries, net of tax	0	0
Net income (loss)	7.2	(10.8)
Other comprehensive income (loss)	0	(0.2)
Total comprehensive income (loss)	7.2	(11.0)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	7.2	(10.8)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.5	0.9
Receivables, net	175.1		152.2
Other current assets	48.8		63.9
Total current assets	225.4		216.8
Property, plant and equipment, net	183.0		196.2
Investment in CyrusOne	462.2		471.0
Goodwill and intangibles, net	103.4		103.8
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	193.4		178.9
Total assets	1,167.4		1,166.7
Current portion of long-term debt	3.0		3.3
Accounts payable	56.4		42.5
Other current liabilities	33.5		34.6
Total current liabilities	92.9		80.4
Long-term debt, less current portion	190.9		194.7
Other noncurrent liabilities	50.7		59.0
Intercompany payables	192.6		199.7
Total liabilities	527.1		533.8
Shareowners' (deficit) equity	640.3		632.9
Total liabilities and shareowners' equity (deficit)	1,167.4		1,166.7
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	15.2	27.6
Capital expenditures	(11.7)	(18.7)
Proceeds from sale of assets	1.8	0
Dividends received from CyrusOne	7.1
Cash divested from deconsolidation of CyrusOne		(12.2)
Other investing activities		0.4
Cash flows used in investing activities	(2.8)	(30.5)
Funding between Parent and subsidiaries, net	(7.1)	(13.8)
(Decrease) increase in receivables facility, net	(1.6)	2.0
Repayment of debt	(2.9)	(2.3)
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(11.6)	(14.1)
(Decrease) increase in cash and cash equivalents	0.8	(17.0)
Cash and cash equivalents at beginning of period	0.7	17.9
Cash and cash equivalents at end of period	1.5	0.9
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	163.3	159.3
Operating costs and expenses	112.9	111.1
Operating (loss) income	50.4	48.2
Interest expense (income), net	(0.8)	4.5
Other (income) expense, net	1.9	1.7
(Loss) income before equity in earnings of subsidiaries and income taxes	49.3	42.0
Income tax (benefit) expense	18.1	16.5
Equity in earnings of subsidiaries, net of tax	0	0
Net income (loss)	31.2	25.5
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	31.2	25.5
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	31.2	25.5
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0.8	1.3
Receivables, net	0		0
Other current assets	23.6		24.1
Total current assets	24.4		25.9
Property, plant and equipment, net	709.1		706.5
Investment in CyrusOne	0		0
Goodwill and intangibles, net	2.2		2.3
Investments in and advances to subsidiaries	277.7		247.7
Other noncurrent assets	5.8		6.1
Total assets	1,019.2		988.5
Current portion of long-term debt	3.7		3.9
Accounts payable	55.1		45.9
Other current liabilities	42.1		49.4
Total current liabilities	100.9		99.2
Long-term debt, less current portion	140.5		141.8
Other noncurrent liabilities	171.4		172.2
Intercompany payables	0		0
Total liabilities	412.8		413.2
Shareowners' (deficit) equity	606.4		575.3
Total liabilities and shareowners' equity (deficit)	1,019.2		988.5
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	52.5	42.2
Capital expenditures	(22.6)	(32.2)
Proceeds from sale of assets	0.1	0.8
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	(22.5)	(31.4)
Funding between Parent and subsidiaries, net	(30.0)	(10.6)
(Decrease) increase in receivables facility, net	0	0
Repayment of debt	(1.0)	(0.8)
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(31.0)	(11.4)
(Decrease) increase in cash and cash equivalents	(1.0)	(0.6)
Cash and cash equivalents at beginning of period	1.8	1.9
Cash and cash equivalents at end of period	0.8	1.3
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	(14.4)	(14.1)
Operating costs and expenses	(14.4)	(14.1)
Operating (loss) income	0	0
Interest expense (income), net	0	0
Other (income) expense, net	0	0
(Loss) income before equity in earnings of subsidiaries and income taxes	0	0
Income tax (benefit) expense	0	0
Equity in earnings of subsidiaries, net of tax	(38.4)	(14.7)
Net income (loss)	(38.4)	(14.7)
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	(38.4)	(14.7)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(38.4)	(14.7)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0	0
Receivables, net	0		0
Other current assets	(0.6)		(0.7)
Total current assets	(0.6)		(0.7)
Property, plant and equipment, net	0		0
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	(1,715.3)		(1,654.3)
Other noncurrent assets	(163.9)		(167.8)
Total assets	(1,879.8)		(1,822.8)
Current portion of long-term debt	0		0
Accounts payable	0		0
Other current liabilities	0		0.1
Total current liabilities	0		0.1
Long-term debt, less current portion	0		0
Other noncurrent liabilities	(164.5)		(168.6)
Intercompany payables	(468.6)		(446.1)
Total liabilities	(633.1)		(614.6)
Shareowners' (deficit) equity	(1,246.7)		(1,208.2)
Total liabilities and shareowners' equity (deficit)	(1,879.8)		(1,822.8)
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	0	0
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	0	0
(Decrease) increase in receivables facility, net	0	0
Repayment of debt	0	0
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	0	0
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Notes guaranteed by subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	322.5	325.7
Operating costs and expenses	265.6	306.5
Operating (loss) income	56.9	19.2
Interest expense (income), net	40.3	47.9
Other (income) expense, net	0.1	1.6
(Loss) income before equity in earnings of subsidiaries and income taxes	16.5	(30.3)
Income tax (benefit) expense	9.5	6.4
Equity in earnings of subsidiaries, net of tax	0	0
Net income (loss)	7.0	(36.7)
Other comprehensive income (loss)	1.8	2.6
Total comprehensive income (loss)	8.8	(34.1)
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	4.4	(39.3)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	4.2	5.1
Receivables, net	177.0		154.8
Other current assets	92.2		91.7
Total current assets	273.4		251.1
Property, plant and equipment, net	892.2		902.8
Investment in CyrusOne	462.2		471.0
Goodwill and intangibles, net	105.6		106.1
Investments in and advances to subsidiaries	0		0
Other noncurrent assets	368.1		376.3
Total assets	2,101.5		2,107.3
Current portion of long-term debt	12.1		12.6
Accounts payable	112.0		89.9
Other current liabilities	141.6		151.8
Total current liabilities	265.7		254.3
Long-term debt, less current portion	2,244.1		2,252.6
Other noncurrent liabilities	262.4		277.1
Intercompany payables	0		0
Total liabilities	2,772.2		2,784.0
Shareowners' (deficit) equity	(670.7)		(676.7)
Total liabilities and shareowners' equity (deficit)	2,101.5		2,107.3
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	37.8	42.3
Capital expenditures	(34.3)	(50.9)
Proceeds from sale of assets	1.9	0.8
Dividends received from CyrusOne	7.1
Cash divested from deconsolidation of CyrusOne		(12.2)
Other investing activities		0.4
Cash flows used in investing activities	(25.3)	(61.9)
Funding between Parent and subsidiaries, net	0	0
(Decrease) increase in receivables facility, net	(4.1)	2.0
Repayment of debt	(5.2)	(3.1)
Proceeds from exercise of options and warrants	0.6	6.6
Other financing activities	(4.2)	(4.4)
Cash flows provided by (used in) financing activities	(12.9)	1.1
(Decrease) increase in cash and cash equivalents	(0.4)	(18.5)
Cash and cash equivalents at beginning of period	4.6	23.6
Cash and cash equivalents at end of period	4.2	5.1
Notes guaranteed by subsidiaries [Member] | Parent Company [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	0	0
Operating costs and expenses	6.1	36.1
Operating (loss) income	(6.1)	(36.1)
Interest expense (income), net	37.1	35.8
Other (income) expense, net	(0.3)	(0.4)
(Loss) income before equity in earnings of subsidiaries and income taxes	(42.9)	(71.5)
Income tax (benefit) expense	(11.5)	(20.1)
Equity in earnings of subsidiaries, net of tax	38.4	14.7
Net income (loss)	7.0	(36.7)
Other comprehensive income (loss)	1.8	2.8
Total comprehensive income (loss)	8.8	(33.9)
Preferred stock dividends	2.6	2.6
Net income (loss) applicable to common shareowners	4.4	(39.3)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.9	2.9
Receivables, net	1.9		2.6
Other current assets	20.4		4.4
Total current assets	24.2		9.1
Property, plant and equipment, net	0.1		0.1
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	1,437.6		1,406.6
Other noncurrent assets	332.8		359.1
Total assets	1,794.7		1,774.9
Current portion of long-term debt	5.4		5.4
Accounts payable	0.5		1.5
Other current liabilities	66.0		67.7
Total current liabilities	71.9		74.6
Long-term debt, less current portion	1,912.7		1,916.1
Other noncurrent liabilities	204.8		214.5
Intercompany payables	276.0		246.4
Total liabilities	2,465.4		2,451.6
Shareowners' (deficit) equity	(670.7)		(676.7)
Total liabilities and shareowners' equity (deficit)	1,794.7		1,774.9
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	(29.9)	(27.5)
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	37.1	24.4
(Decrease) increase in receivables facility, net	(2.5)	0
Repayment of debt	(1.3)	0
Proceeds from exercise of options and warrants	0.6	6.6
Other financing activities	(4.2)	(4.4)
Cash flows provided by (used in) financing activities	29.7	26.6
(Decrease) increase in cash and cash equivalents	(0.2)	(0.9)
Cash and cash equivalents at beginning of period	2.1	3.8
Cash and cash equivalents at end of period	1.9	2.9
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	187.1	175.7
Operating costs and expenses	172.9	170.1
Operating (loss) income	14.2	5.6
Interest expense (income), net	3.6	3.9
Other (income) expense, net	3.5	4.7
(Loss) income before equity in earnings of subsidiaries and income taxes	7.1	(3.0)
Income tax (benefit) expense	2.3	9.5
Equity in earnings of subsidiaries, net of tax	0	0.7
Net income (loss)	4.8	(11.8)
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	4.8	(11.8)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	4.8	(11.8)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.1	0.4
Receivables, net	9.4		7.2
Other current assets	45.1		60.7
Total current assets	55.6		68.2
Property, plant and equipment, net	182.6		194.1
Investment in CyrusOne	462.2		471.0
Goodwill and intangibles, net	103.4		103.8
Investments in and advances to subsidiaries	(1.7)		(1.6)
Other noncurrent assets	194.6		179.9
Total assets	996.7		1,015.4
Current portion of long-term debt	3.0		3.0
Accounts payable	79.7		72.3
Other current liabilities	35.3		36.9
Total current liabilities	118.0		112.2
Long-term debt, less current portion	86.3		87.0
Other noncurrent liabilities	53.1		61.3
Intercompany payables	129.4		149.9
Total liabilities	386.8		410.4
Shareowners' (deficit) equity	609.9		605.0
Total liabilities and shareowners' equity (deficit)	996.7		1,015.4
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	26.7	(8.4)
Capital expenditures	(11.7)	(11.0)
Proceeds from sale of assets	0	0
Dividends received from CyrusOne	7.1
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	(4.6)	(11.0)
Funding between Parent and subsidiaries, net	(20.6)	21.0
(Decrease) increase in receivables facility, net	0	0
Repayment of debt	(0.7)	(1.5)
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(21.3)	19.5
(Decrease) increase in cash and cash equivalents	0.8	0.1
Cash and cash equivalents at beginning of period	0.3	0.3
Cash and cash equivalents at end of period	1.1	0.4
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	149.8	164.1
Operating costs and expenses	101.0	114.4
Operating (loss) income	48.8	49.7
Interest expense (income), net	(0.4)	8.2
Other (income) expense, net	(3.1)	(2.7)
(Loss) income before equity in earnings of subsidiaries and income taxes	52.3	44.2
Income tax (benefit) expense	18.7	17.0
Equity in earnings of subsidiaries, net of tax	0	0
Net income (loss)	33.6	27.2
Other comprehensive income (loss)		(0.2)
Total comprehensive income (loss)	33.6	27.0
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	33.6	27.2
Condensed Consolidating Balance Sheets
Cash and cash equivalents	1.2	1.8
Receivables, net	165.7		145.0
Other current assets	27.3		27.3
Total current assets	194.2		174.5
Property, plant and equipment, net	709.5		708.6
Investment in CyrusOne	0		0
Goodwill and intangibles, net	2.2		2.3
Investments in and advances to subsidiaries	254.6		218.2
Other noncurrent assets	4.6		5.1
Total assets	1,165.1		1,108.7
Current portion of long-term debt	3.7		4.2
Accounts payable	31.8		16.1
Other current liabilities	40.3		47.1
Total current liabilities	75.8		67.4
Long-term debt, less current portion	245.1		249.5
Other noncurrent liabilities	169.0		169.9
Intercompany payables	51.9		33.2
Total liabilities	541.8		520.0
Shareowners' (deficit) equity	623.3		588.7
Total liabilities and shareowners' equity (deficit)	1,165.1		1,108.7
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	41.0	78.2
Capital expenditures	(22.6)	(39.9)
Proceeds from sale of assets	1.9	0.8
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		(12.2)
Other investing activities		0.4
Cash flows used in investing activities	(20.7)	(50.9)
Funding between Parent and subsidiaries, net	(16.5)	(45.4)
(Decrease) increase in receivables facility, net	(1.6)	2.0
Repayment of debt	(3.2)	(1.6)
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	(21.3)	(45.0)
(Decrease) increase in cash and cash equivalents	(1.0)	(17.7)
Cash and cash equivalents at beginning of period	2.2	19.5
Cash and cash equivalents at end of period	1.2	1.8
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member]
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss)
Revenue	(14.4)	(14.1)
Operating costs and expenses	(14.4)	(14.1)
Operating (loss) income	0	0
Interest expense (income), net	0	0
Other (income) expense, net	0	0
(Loss) income before equity in earnings of subsidiaries and income taxes	0	0
Income tax (benefit) expense	0	0
Equity in earnings of subsidiaries, net of tax	(38.4)	(15.4)
Net income (loss)	(38.4)	(15.4)
Other comprehensive income (loss)	0	0
Total comprehensive income (loss)	(38.4)	(15.4)
Preferred stock dividends	0	0
Net income (loss) applicable to common shareowners	(38.4)	(15.4)
Condensed Consolidating Balance Sheets
Cash and cash equivalents	0	0
Receivables, net	0		0
Other current assets	(0.6)		(0.7)
Total current assets	(0.6)		(0.7)
Property, plant and equipment, net	0		0
Investment in CyrusOne	0		0
Goodwill and intangibles, net	0		0
Investments in and advances to subsidiaries	(1,690.5)		(1,623.2)
Other noncurrent assets	(163.9)		(167.8)
Total assets	(1,855.0)		(1,791.7)
Current portion of long-term debt	0		0
Accounts payable	0		0
Other current liabilities	0		0.1
Total current liabilities	0		0.1
Long-term debt, less current portion	0		0
Other noncurrent liabilities	(164.5)		(168.6)
Intercompany payables	(457.3)		(429.5)
Total liabilities	(621.8)		(598.0)
Shareowners' (deficit) equity	(1,233.2)		(1,193.7)
Total liabilities and shareowners' equity (deficit)	(1,855.0)		(1,791.7)
Condensed Consolidating Statements of Cash Flows
Cash flows (used in) provided by operating activities	0	0
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Dividends received from CyrusOne	0
Cash divested from deconsolidation of CyrusOne		0
Other investing activities		0
Cash flows used in investing activities	0	0
Funding between Parent and subsidiaries, net	0	0
(Decrease) increase in receivables facility, net	0	0
Repayment of debt	0	0
Proceeds from exercise of options and warrants	0	0
Other financing activities	0	0
Cash flows provided by (used in) financing activities	0	0
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Various Cincinnati Bell Telephone Notes [Member]
Condensed Financial Statements, Captions [Line Items]
Debt Instrument, Face Amount	$ 134.5		$ 134.5